Keyphrases
Cell Death
100%
Tumoral
100%
Syngeneic Mice
100%
Anti-tumor Immune
100%
T-lymphoblasts
100%
Tumor Regression
100%
Tumor Cell Lysate
100%
L5178Y
100%
Immune System Stimulation
100%
Tumor
75%
Tumor Cells
50%
Acute Lymphoblastic Leukemia
50%
Tumor Establishment
50%
Immune Tolerance
50%
Low Immunogenicity
50%
Cluster of Differentiation 47 (CD47)
50%
T-cell ALL
50%
T Cells
25%
Treatment Options
25%
Immunogenicity
25%
Potential Therapeutics
25%
Cytokine Production
25%
Induced Damage
25%
Therapeutic Tool
25%
Rechallenge
25%
Anti-tumor Response
25%
Antitumor Immune Response
25%
Overall Survival
25%
Dendritic Cell Maturation
25%
Lymphoblast
25%
Immunogenic Potential
25%
Thrombospondin-1 (TSP-1)
25%
Damage-associated Molecular Patterns
25%
Murine Tumors
25%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
25%
Cell Treatment
25%
Production Cell
25%
Prophylactic Vaccination
25%
Pediatric Cancer
25%
Hematological Cancer
25%
Agonist Peptide
25%
Immunogenic Cell Death
25%
Calreticulin Exposure
25%
Leukemia Relapse
25%
Immunology and Microbiology
Tumor Cell
100%
Cell Death
100%
Cell Lysate
100%
Syngenic
100%
T Lymphoblast
100%
Immune System
100%
T Cell
80%
Immunogenicity
60%
Immunotherapy
40%
Immune Tolerance
40%
CD47
40%
Cell Maturation
20%
Immune Response
20%
Cell Line
20%
Agonist
20%
Cytokine Production
20%
Dendritic Cell
20%
Murine
20%
Overall Survival
20%
Lymphoblast Cell Line
20%
Thrombospondin 1
20%
Calreticulin
20%
Peptides
20%